Evaluation of a Novel Left Ventricular Assist Device for Resuscitation in an Animal Model of Ventricular Fibrillation Cardiac Arrest
Open Access
- 13 December 2021
- journal article
- research article
- Published by Institute of Electrical and Electronics Engineers (IEEE) in IEEE Journal of Translational Engineering in Health and Medicine
- Vol. 10, 1-7
Abstract
We evaluated an independently developed novel percutaneous implantable left ventricular assist device for resuscitation in a pig model of ventricular fibrillation cardiac arrest. The model was established in 10 domestic pigs by blocking the anterior descending coronary artery with a balloon after anesthesia. With ventilator-assisted ventilation, the independently developed percutaneous implantable left ventricular assist device was inserted via the femoral artery to assist circulation. According to whether effective circulatory support was achieved, the pigs were randomly divided into an experimental group and a control group. The experimental group was subjected to insertion of the assist device and received continuous circulatory support. The control group underwent insertion of the assist device; however, it did not start it within 15 minutes. For all animals, if successful rescue was achieved (sinus rhythm restoration within 15 minutes and maintenance for over 5 minutes), circulatory support was stopped, and the arterial blockage was removed. If sinus rhythm was not restored within 15 minutes, electric defibrillation, adrenaline injection, and removal of the arterial blockage were performed, and circulatory support was provided until sinus rhythm recovered. A determination of failed rescue was made when sinus rhythm was not restored after 1 hour. All successfully rescued animals were fed for 1 week. There were no significant differences in baseline data between the groups. All animals underwent successful novel left ventricular assist device implantation through the femoral artery. The rescue rate was significantly higher in the experimental group than in the control group (80% vs. 0%, P = 0.01). All successfully rescued animals survived after 1 week of feeding, and no eating or movement abnormalities were observed. We conclude that this independently developed percutaneous implantable left ventricular assist device can be conveniently and rapidly implanted through the femoral artery and can maintain basic circulatory perfusion during resuscitation in an animal model of cardiac arrest.Keywords
Funding Information
- Guangdong Medical Science Research Foundation (A2020626)
This publication has 19 references indexed in Scilit:
- Executive Summary: Heart Disease and Stroke Statistics—2016 UpdateCirculation, 2016
- Cardiac ArrestCirculation Research, 2015
- Advanced (Stage D) Heart Failure: A Statement From the Heart Failure Society of America Guidelines CommitteeJournal of Cardiac Failure, 2015
- Trends in Survival after In-Hospital Cardiac ArrestNew England Journal of Medicine, 2012
- Intraaortic Balloon Support for Myocardial Infarction with Cardiogenic ShockNew England Journal of Medicine, 2012
- A Prospective, Randomized Clinical Trial of Hemodynamic Support With Impella 2.5 Versus Intra-Aortic Balloon Pump in Patients Undergoing High-Risk Percutaneous Coronary InterventionCirculation, 2012
- Blood Trauma Testing of CentriMag and RotaFlow Centrifugal Flow Devices: A Pilot StudyArtificial Organs, 2012
- The Percutaneous Ventricular Assist Device in Severe Refractory Cardiogenic ShockJACC, 2011
- A Prospective Feasibility Trial Investigating the Use of the Impella 2.5 System in Patients Undergoing High-Risk Percutaneous Coronary Intervention (The PROTECT I Trial)JACC: Cardiovascular Interventions, 2009
- The use of intra-aortic balloon counterpulsation in patients with cardiogenic shock complicating acute myocardial infarction: Data from the National Registry of Myocardial Infarction 2American Heart Journal, 2001